SAMe Trial for Patients With Alcoholic Cirrhosis

Status Recruiting

Clinical Trial Summary

The proposed of this randomized, double blinded, placebo-controlled study is to assess the effect of SAMe compared to placebo in patients with alcoholic cirrhosis Child Class A and B. The primary objective of the study is to test relationship between SAMe (S-adenosylmethionine) supplement on liver function. The hypothesis is that SAMe supplement will improve liver function in patients with alcoholic liver disease. The improvement in liver function will lead to the reduction in all-cause mortality in patients with alcoholic cirrhosis in those who receive SAMe supplement when compared to those receiving placebo.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04250259
Study type	Interventional
Source	Indiana University
Contact	Kristina Chandler, BS
Phone	(317) 988-4733
Email	krimhick@iu.edu
Status	Recruiting
Phase	Phase 2
Start date	October 22, 2020
Completion date	September 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04106518` - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Completed	`NCT01065233` - Pangenomic Study During Alcoholic Cirrhosis
Active, not recruiting	`NCT01213927` - National Cohort of Uncomplicated Alcoholic Cirrhosis
Completed	`NCT00388323` - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human	N/A
Terminated	`NCT01342705` - Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis	Phase 3
Recruiting	`NCT04689152` - Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis	Phase 3
Recruiting	`NCT05155657` - Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells	Phase 1
Terminated	`NCT03534141` - Mild Hypothermia and Acute Kidney Injury in Liver Transplantation	N/A
Completed	`NCT02072746` - Zinc Supplementation in Alcoholic Cirrhosis	N/A
Completed	`NCT00827723` - Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
Recruiting	`NCT04245189` - EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis
Completed	`NCT01756794` - Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment	N/A
Recruiting	`NCT05093881` - Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study	N/A
Terminated	`NCT03508388` - Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
Completed	`NCT02326103` - Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis	Phase 0
Terminated	`NCT00188045` - Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients	Phase 4
Withdrawn	`NCT04070508` - Early Detection of Alcoholic Liver Disease
Recruiting	`NCT04363424` - Alcohol Biomarker Study